SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-21-004156
Filing Date
2021-03-08
Accepted
2021-03-08 16:08:05
Documents
16
Period of Report
2021-03-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K cerc-20210308.htm   iXBRL 8-K 33457
2 EX-99.1 ex-991earningsreleaseq42020.htm EX-99.1 110314
8 cerecorlogoa711a.jpg GRAPHIC 16081
  Complete submission text file 0001628280-21-004156.txt   315039

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cerc-20210308.xsd EX-101.SCH 2458
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cerc-20210308_cal.xml EX-101.CAL 744
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cerc-20210308_def.xml EX-101.DEF 1689
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cerc-20210308_lab.xml EX-101.LAB 23312
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cerc-20210308_pre.xml EX-101.PRE 12151
9 EXTRACTED XBRL INSTANCE DOCUMENT cerc-20210308_htm.xml XML 9975
Mailing Address 540 GAITHER ROAD SUITE 400 ROCKVILLE MD 20850
Business Address 540 GAITHER ROAD SUITE 400 ROCKVILLE MD 20850 410-522-8707
Cerecor Inc. (Filer) CIK: 0001534120 (see all company filings)

IRS No.: 450705648 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37590 | Film No.: 21721996
SIC: 2834 Pharmaceutical Preparations